Next Generation Of Clinical Monitoring | Part 2: Detecting Clinical Trial Fraud & Misconduct

The integrity of data and ethical standards are of utmost importance in the constantly changing world of clinical trials. As trials become more complex, identifying instances of misconduct and fraud becomes increasingly difficult, especially with the explosion of data points, which now average at 3.6 million in Phase III trials. However, with the introduction of modern data and surveillance technologies, a new era of monitoring has begun.

In the second part of this series, we will take a closer look at the critical task of detecting fraud and misconduct in clinical trials. We will explore why it is important, examine the various types of malpractice, and discover how centralized monitoring, powered by advanced analytics and real-time data aggregation, is revolutionizing the fight against deceit. Last, you will learn how industry-leading solutions like Medidata Detect are reshaping risk management, ensuring trial integrity, and safeguarding the well-being of patients and stakeholders.